Tag: PUBLIC HEALTH INFORMATION

WHO: Global COVID-19 Case Counts Decline 17 Percent in Latest Week

GENEVA—The World Health Organization says coronavirus case counts fell 17 percent worldwide over the last week compared to the previous week, including a 50 percent drop in the United States, while deaths globally declined 7 percent. The weekly epidemiological report from the U.N. health agency, released late Tuesday, shows that the omicron variant is increasingly…


Decades-Old Drug May Help Protect Against Severe COVID-19 Symptoms: Study

A drug that was approved by U.S. regulators more than 70 years ago may help protect against two major COVID-19 symptoms, according to a new study. Disulfiram, approved to treat alcoholism, protected rodents infected with COVID-19 from lung injury in the preclinical study done by researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory. Certain…


COVID-19 Increases Risk of Pregnancy Complications, New Study Suggests

Pregnant women infected with COVID-19 appear to be at greater risk of experiencing common pregnancy complications compared to women who are uninfected, according to a new study. The National Institutes of Health (NIH) funded study included data from more than 13,000 pregnant women from 17 medical centers across the nation. Of those participants, nearly 2,400…


First Leukemia Patients Treated With Experimental Therapy Remained in Remission 10 Years Later: Study

Researchers of a new study say that two patients with leukemia continued to be in remission a decade after they were first infused with the experimental CAR T-cell therapy that turned their immune cells into cancer-killing cells. In 2010, Doug Olson and Bill Ludwig, participated in an experimental phase 1 clinical trial of the immunotherapy,…


First Patients Treated With Experimental Therapy Remained in Remission 10 Years Later: Study

Researchers of a new study say that two patients with leukemia continued to be in remission a decade after they were first infused with the experimental CAR T-cell therapy that turned their immune cells into cancer-killing cells. In 2010, Doug Olson and Bill Ludwig, participated in an experimental phase 1 clinical trial of the immunotherapy,…


CDC to Ramp Up Wastewater Surveillance Scheme to Boost COVID-19 Tracking Efforts

The Centers for Disease Control and Prevention (CDC) said Friday it’s expanding a wastewater surveillance program to enhance efforts to track COVID-19 infections across the United States. “Go on, get the sewer jokes out of your system,” the CDC said in a note in October 2020, shortly after it first launched the scheme, called the National…


Dr. Ryan Cole: Clinical Studies Needed as Uptick in Cancers Observed After COVID-19 Vaccine Rollout

Dr. Ryan Cole, pathologist and founder of Cole Diagnostics, says that he is observing a concerning pattern of certain cancers after the rollout of the COVID-19 vaccines and that rigorous studies need to be conducted. “In the laboratory, I’m seeing an uptick in cancers that I shouldn’t be seeing at rates I shouldn’t be seeing…


Natural Immunity to COVID-19 Detected at 20 Months After Infection: Study

Protection against the virus that causes COVID-19 among the recovered was detected by researchers at 20 months post-infection, adding to the body of evidence that such protection, known as natural immunity, is long-lasting. Researchers found antibodies against the SARS-CoV-2 spike protein receptor-binding domain (RBD) in 99 percent of study participants who tested positive for COVID-19,…


Vitamin D Deficiency Linked to Severe, Deadly COVID-19: Study

People who are vitamin D deficient are 14 times more likely to have severe COVID-19 and to die from the disease, according to research from scientists in Israel. The peer-reviewed study, published in the journal PLoS ONE, looked at vitamin D levels before a person contracted COVID-19 and the disease’s severity and mortality. Researchers from Azrieli Faculty of…


Findings Announced From UK Study That Purposefully Infected Participants With COVID-19

COVID-19 symptoms develop more quickly than most experts thought, according to the first findings from a study that purposefully infected volunteers with the disease. Participants experienced symptoms on average two days after contact with the CCP (Chinese Communist Party) virus, which causes COVID-19, the study found. Detection of the virus in infected individuals came initially by using…